The Creation and Development of Practical Science Related to Health-longevity:
The validity of the selected biomarkers signaling risks of lifestyle-related diseases will be investigated in animal models and in human subjects for application to clinical trials. To evaluate and monitor the efficacy of individualized food selection in combination with drug use, ‘individual metabolic profiling’ data will be collected and analyzed. This approach will serve as the basis for personalized dietary and drug dosage regimens, taking into account the individual’s metabolic state and genetic background.